DOI:
10.1055/s-00000125
Senologie - Zeitschrift für Mammadiagnostik und -therapie
LinksClose Window
References
Blackwell K, Miles D, Gianni L et al.
Primary results from EMILIA, a phase 3 study of trastuzumab emtansin (T-DM1) vs capecitabine and lapatinib in HER2-positive locally advanced or metastatic breast cancer previously treated with trastuzumab and a taxane.
ASCO JCO 2012;
30: LBA1
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.